Low influenza vaccination rate among patients with systemic sclerosis

Abstract

Objective. To evaluate the influenza vaccination rate and factors influencing it in patients with SSc. Results. Mean (S.D.) age and disease duration were 58.7 (12.6) and 10.5 (9.5) years, respectively. Overall, 69 (39%) patients received an influenza vaccination during the previous year. Among the 108 patients who were not vaccinated, 78 (72.2%) presented at least one indication for vaccination. The most frequent reasons for non-vaccination were absence of physician recommendation and fear of side effects. Patients who were and were not vaccinated did not differ in anxiety, depression, global disability or quality of life. Vaccination rate was significantly higher (59%) for patients who remembered receiving a letter from the French National Health Insurance Agency encouraging vaccination than among those who did not (26%, P = 0.0001). Multivariate analysis revealed the year of the last vaccination and age as two independent parameters associated with vaccination.Conclusions. Influenza vaccination coverage is low in SSc patients. Lack of information and fear of adverse effects are the most common reasons for non-vaccination. Efforts are needed to increase the influenza vaccination coverage in this population.

Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency

“…Literature review highlights three main findings supported by our study: vaccine coverage rates against influenza and pneumococcus are always suboptimal (from 34% to 63% and from 11%% to 39%, respectively) [36][37][38][39][40]; pneumococcal vaccination uptakes are lower than influenza vaccine uptakes; and vaccine uptake rates vary according to disease groups [35,[41][42][43].…”

“…The reported rate of vaccination against pneumococcus was 49% (95%CI [47][48][49][50]); 51% (95%CI [49-53]) in the AI group, 36% (95%CI [30][31][32][33][34][35][36][37][38][39][40][41][42][43]) in the Tx group and 39% (95%CI [33][34][35][36][37][38][39][40][41][42][43][44]) in the MBD group (Table 3).…”

Vaccination antigrippale chez les patients atteints de maladies systémiques inflammatoires et/ou auto-immunes

“…Malgré les recommandations, les données disponibles montrent une couverture vaccinale antigrippale très faible dans ces populations : 57 % dans une étude réalisée chez des patients traités pour une PR [45], 28 % dans une population traitée par immunosuppresseurs pour une maladie inflammatoire chronique intestinale (MICI) [46], 28 % chez des patients traités par immunosuppresseurs pour une maladie inflammatoire chronique dans le pôle de médecine interne de l'hôpital Cochin [47] ou encore 39 % dans une étude française menée chez des patients suivis pour une sclérodermie systémique [48]. …”

Immunizations in Adult Patients with Systemic Sclerosis

“…Among these 177 patients, only 68 (38.4%) had received flu shots during the past year: 50.7% of the patients ≥ 65 years old versus only 22% of those < 65 years. The most frequently evocated reasons for nonvaccination were doctor's lack of recommendation, fear of side effects, and fear of inefficacy 59 …”